- Home
- TALKW vs FBIOP Comparison
TALKW vs FBIOP Comparison
Compare TALKW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALKW
- FBIOP
- Stock Information
- Founded
- TALKW 2012
- FBIOP N/A
- Country
- TALKW United States
- FBIOP United States
- Employees
- TALKW N/A
- FBIOP 186
- Industry
- TALKW Medical/Nursing Services
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- TALKW Health Care
- FBIOP Health Care
- Exchange
- TALKW Nasdaq
- FBIOP Nasdaq
- Market Cap
- TALKW N/A
- FBIOP N/A
- IPO Year
- TALKW N/A
- FBIOP N/A
- Fundamental
- Price
- TALKW $0.16
- FBIOP $6.04
- Analyst Decision
- TALKW
- FBIOP
- Analyst Count
- TALKW 0
- FBIOP 0
- Target Price
- TALKW N/A
- FBIOP N/A
- AVG Volume (30 Days)
- TALKW 64.2K
- FBIOP N/A
- Earning Date
- TALKW 02-20-2025
- FBIOP N/A
- Dividend Yield
- TALKW N/A
- FBIOP N/A
- EPS Growth
- TALKW N/A
- FBIOP N/A
- EPS
- TALKW N/A
- FBIOP N/A
- Revenue
- TALKW $181,291,000.00
- FBIOP N/A
- Revenue This Year
- TALKW N/A
- FBIOP N/A
- Revenue Next Year
- TALKW N/A
- FBIOP N/A
- P/E Ratio
- TALKW N/A
- FBIOP N/A
- Revenue Growth
- TALKW 31.50
- FBIOP N/A
- 52 Week Low
- TALKW $0.20
- FBIOP N/A
- 52 Week High
- TALKW $0.24
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- TALKW N/A
- FBIOP 35.35
- Support Level
- TALKW N/A
- FBIOP $6.22
- Resistance Level
- TALKW N/A
- FBIOP $6.53
- Average True Range (ATR)
- TALKW 0.00
- FBIOP 0.29
- MACD
- TALKW 0.00
- FBIOP -0.06
- Stochastic Oscillator
- TALKW 0.00
- FBIOP 14.00
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.